Company & Sponsor Intelligence
University Hospitals Cleveland Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials8
Recruiting2
Completed5
Countries1
Therapeutic footprint
alzheimersautismbipolar_disorderepilepsyhuntingtons
Indexed studies
NCT06346262Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care
epilepsy · United StatesPHASE4
epilepsy · United StatesPHASE4
NCT03819439Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT01560585Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease
alzheimers · United StatesPHASE1, PHASE2
alzheimers · United StatesPHASE1, PHASE2
NCT03829787Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
bipolar_disorder · United StatesRECRUITING
bipolar_disorder · United StatesRECRUITING
NCT00830310Customized Medication Adherence Enhancement for Adults With Bipolar Disorder
bipolar_disorder · United StatesNA
bipolar_disorder · United StatesNA
NCT01293825Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
bipolar_disorder · United StatesPHASE4
bipolar_disorder · United StatesPHASE4
NCT04515550Mitochondrial Biomarkers in Huntington's Disease
huntingtons · United StatesCOMPLETED
huntingtons · United StatesCOMPLETED
NCT00921297Cataract Removal and Alzheimer's Disease
alzheimers · United StatesNA
alzheimers · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →